X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EXPERIMENTAL AND MOLECULAR PATHOLOGY

期刊標題檢索 EXP MOL PATHOL 最新評論: Do we need to pay for page fees as long as our paper is accepted? (2022-05-22)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EXPERIMENTAL AND MOLECULAR PATHOLOGY]您好,您是該頁面的第 37190 位訪客。

期刊簡介
期刊名稱EXPERIMENTAL AND MOLECULAR PATHOLOGY EXPERIMENTAL AND MOLECULAR PATHOLOGY
LetPub Score
4.7
50 ratings
Rate

Reputation
3.9

Influence
4.9

Speed
7.0

期刊簡稱EXP MOL PATHOL
ISSN0014-4800
E-ISSN1096-0945
h-index60
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.900.7260.685
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q115 / 208
Category: Medicine
Subcategory: Clinical Biochemistry
Q122 / 117
Category: Medicine
Subcategory: Molecular Biology
Q197 / 410

自引率 (2023-2024)3.60%自引率趨勢
掲載範囲
Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.

Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.
官方網站http://www.journals.elsevier.com/experimental-and-molecular-pathology/
在線稿件提交https://www.editorialmanager.com/EMP
開放訪問No
出版商Academic Press Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1962
每年文章數14每年文章數趨勢
黃金OA百分比27.88%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PATHOLOGYSCIEQ230/88
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0014-4800%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 4.5 Month(s)
來自Elsevier的數據: Average 11.5 Week(s)
競爭力 *來自作者的數據: About 62.5%
來自Elsevier的數據: 17%
在線文章發布時間來自Elsevier的數據: Average 3.3 Week(s)
參考鏈接
相關期刊 【EXPERIMENTAL AND MOLECULAR PATHOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF PATHOLOGYH-index: 258

    CiteScore: 11.40
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports321597
    DISEASE MARKERS95488
    PATHOLOGY RESEARCH AND PRACTICE68901
    LABORATORY INVESTIGATION67723
    JOURNAL OF PATHOLOGY65849
    AMERICAN JOURNAL OF PATHOLOGY61296
    Diagnostic Pathology44567
    ACTA NEUROPATHOLOGICA44282
    PATHOLOGY & ONCOLOGY RESEARCH43806
    MODERN PATHOLOGY41830
  •  

    EXPERIMENTAL AND MOLECULAR PATHOLOGY EXPERIMENTAL AND MOLECULAR PATHOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [EXPERIMENTAL AND MOLECULAR PATHOLOGY] 的評論撰寫評論
作者: 长安雯华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-22 12:39:19 評論於
Do we need to pay for page fees as long as our paper is accepted?
(0) 讚! | 长安雯华

作者: Ann


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-15 09:48:17 評論於
Cover yourself with a blanket and find a comfortable sleeping position
(0) 讚! | Ann

作者: 狮吼问梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-08 19:04:25 評論於
So many magazines have been downgraded this year, but unfortunately this one has been upgraded to advanced and intermediate alerts... It's too scary... Invest with caution
(0) 讚! | 狮吼问梅

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:08:30 評論於
Articles achieving a score of 7 or above will only require additional data and results to be included for publication
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:14:51 評論於
Sufficient experimental data results and well-written articles
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 15:27:21 評論於
Why do I think my paper should only receive a 3-4 grade, but the instructor wants to start grading from a 7?
(0) 讚! | 八坂篷蔚

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:40:02 評論於
What preparations are needed for outdoor activities?
(0) 讚! | 龙鳞孝礼

作者: 璃月盼翠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-02 13:51:10 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Sharing experience: Does anyone know if this journal requires payment of publication fees for publishing articles, or can we avoid paying publication fees if it's not open access?
(0) 讚! | 璃月盼翠

作者: 一条小含海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-13 12:14:31 評論於
Review Speed: 3.0
Experience Sharing: It's too slow, I had to revise it three times before it was finally accepted after nearly half a year. I wonder if it's because there are not many people reviewing due to the pandemic
(0) 讚! | 一条小含海

作者: 雨巷少年惜玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-26 15:42:22 評論於
Do you accept bioinformatics?
(0) 讚! | 雨巷少年惜玉

作者: xxx


領域: 生命科学
審稿時間: 8.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-31 16:26:03 評論於
Still waiting for 8 months! Stay away from this journal.
(1) 讚! | xxx

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 23:50:22 評論於
The downward trend continues, will it break 2? It has fallen quite a bit in just one year, even 0.1 points should be cherished
(0) 讚! | 凌霄高洁

作者: 南川翌耀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-13 10:46:40 評論於
The first review took five months, and the second review took three months after revision. No one reviewed the manuscript, and as a result, it was rejected. I'm speechless
(0) 讚! | 南川翌耀

作者: 江南幼柏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-03-10 10:50:01 評論於
Dear seniors, I am conducting basic research on pulmonary fibrosis animal experiments. Is it appropriate to submit to this journal?
(0) 讚! | 江南幼柏

作者: 雾都阳曜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-08 11:21:50 評論於
It's been three months already, I've sent a few reminder emails, but no one has responded. What should I do? I'm getting anxious
(0) 讚! | 雾都阳曜

作者: 雾都阳曜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-08 09:05:42 評論於
@luowenshu33 Do you have any news now?
(0) 讚! | 雾都阳曜

作者: 雾都阳曜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-06 23:57:49 評論於
Submitted on November 5, 2016 and still waiting for reviewer invitation. I have sent a reminder email once but no one responded. What's going on? Does anyone know? Please help
(0) 讚! | 雾都阳曜

作者: 菩提一瑾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-04 09:42:34 評論於
After more than four months of waiting, the submission was rejected directly
(0) 讚! | 菩提一瑾

作者: Tom Alfred


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-10-27 19:15:37 評論於
What does it mean when the review status is "reviewer invited"? It has been in this status for over two months
(0) 讚! | Tom Alfred

作者: 星熊菊月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-05-15 16:17:04 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: Very formal journal, very diligent editors, very efficient, very lucky to have chosen this journal
(0) 讚! | 星熊菊月

作者: 太极俊明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-04-01 16:12:13 評論於
Is this magazine outdated?
(0) 讚! | 太极俊明

作者: 太极俊明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-02 13:41:59 評論於
@Wax Pen, no reply, no information at all... still under review
(0) 讚! | 太极俊明

作者: Judy Adela


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-02-29 08:38:32 評論於
Has the editor replied to you? I have submitted my article for almost 3 months now and it is still under review
(0) 讚! | Judy Adela

作者: 应龙翠霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-02-25 10:04:29 評論於
I have been submitting the manuscript for a month and a half, with 2 updates during this period, but it is still under review
(0) 讚! | 应龙翠霜

作者: 太极俊明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-02-17 15:55:32 評論於
@Labiexiao is still under review and the editor did not reply to the email
(0) 讚! | 太极俊明

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [EXPERIMENTAL AND MOLECULAR PATHOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*